RELATED CONTENT
At the surface, the term “advanced visualization†seems nebulous at best. Medical imaging technology continues to develop and advance at a rapid rate, so determining what qualifies as advanced remains a moving target as well. In general, however, the current cutting edge of imaging centers around 3-D/4-D viewing and mobile technology, with different specialties implementing them in unique ways.
June 04, 2015 
Coquí RadioPharmaceuticals Corp. is working to become the first commercial producer of lifesaving medical isotopes in the United States.
September 30, 2014 A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow trials of different sizes and durations to be compared easily. This measurement also helps to illustrate the high costs associated with delays.
September 30, 2013 
C. R. Bard Inc. has entered into a definitive merger agreement to acquire Rochester Medical Corp. at a price of $20 per share, or approximately $262 million in the aggregate. The Rochester Medical board of directors unanimously approved the agreement and will recommend that the company's shareholders approve the transaction.
September 04, 2013 
C.R. Bard Inc. has agreed to pay the federal government $48.2 million to settle a whistleblower lawsuit that alleges its urological division and wholly owned subsidiary, ProSeed Inc., paid doctors and hospitals kickbacks to entice them to order Bard's products at inflated prices to treat Medicare patients with prostate cancer.
May 15, 2013 
July 6, 2010 – C. R. Bard Inc. announced today that it has completed its acquisition of SenoRx Inc., a manufacturer of breast cancer treatment devices.
July 06, 2010 August 18, 2008 – Maximus, a business unit of infusion therapy firm Medegen Inc., today announced as a result of a co ...
August 17, 2008 
The FDA recently gave 510(k) clearance for C.R. Bard’s Agento I.C. silver-coated intermediate high volume low pressure ...
June 12, 2008 June 12, 2008 - C.R. Bard Inc. last week said it closed the acquisition of Specialized Health Products International Inc ...
June 11, 2008 April 10, 2008 - The FDA recently gave 510(K) clearance for C.R. Bard’s Agento I.C. silver-coated intermediate high ...
April 09, 2008